Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Red Cross receives two coffins of deceased hostages...
Trump surgeon general nominee confirmation hearing postponed as...
Vance to meet with Duffy, aviation leaders as...
Once a trade war weapon, US soybeans return...
Republican senators blast FDA for expanding abortion pill...
Senate defies Trump on global tariffs as Republicans...
House Republicans divided over Obamacare as GOP eyes...
Thune, GOP reject pushing ‘rifle-shot’ government funding bills...
Trump’s fire fades on Russia as he pulls...
GOP lawmaker says backing Cuomo over ‘communist’ Mamdani...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

Zero Candida Technologies:Pioneering Technology-driven, Innovative Solution for Non-drug Treatment of Candidiasis

by admin December 18, 2024
December 18, 2024
Zero Candida Technologies:Pioneering Technology-driven, Innovative Solution for Non-drug Treatment of Candidiasis

Founded by a team of seasoned entrepreneurs and healthcare experts, Zero Candida (TSXV:ZCT) is a fem-tech pioneer, combining advanced artificial intelligence with non-drug diagnostics and personalized treatment modalities in a single device. The company developed an innovative, first-of-its-kind solution to the diagnosis and treatment of Candidiasis, a fungal infection causing irritation, discharge and intense itchiness of the vagina and the vulva. The device offers precision therapy by eliminating fungal infections with over 99.99 percent effectiveness in just three hours, a revolutionary improvement over existing treatments.

Zero Candida is on track to complete clinical trials and file for FDA approval in 2024 with its innovative technology.

Zero Candida’s SMART vaginal diagnostic device utilizes blue light therapy to treat this widespread condition without drugs. This non-drug therapy addresses key issues associated with conventional antifungal medications, including reduced risk of drug resistance, minimized side effects, and potential for faster symptom relief

Company Highlights

  • Zero Candida Technologies is a fem-tech company focused on developing a SMART diagnostic and therapeutic device aimed at eliminating vaginal candidiasis (commonly known as yeast infection), a condition that affects three out four women globally.
  • Candidiasis a fungal infection causing irritation, discharge and intense itchiness of the vagina and the vulva. In several cases, the current treatment for Candidiasis has been ineffective.
  • Zero Candida has completed proof-of-concept studies, and demonstrated near-complete fungal eradication with over 99.99 percent effectiveness in just three hours.
  • Founded by a team of experienced entrepreneurs and healthcare experts, the company is addressing the significant unmet needs of the women’s health market.
  • The fem-tech segment of the med tech market is expected to grow at a CAGR of 18.2 percent and is estimated to reach nearly US$30 billion by 2032. North America dominated the global fem-tech market with a share of 52.91 percent in 2023.
  • The company has already patented this technology in South Africa, while additional filings for patent application in the US and EU are underway.

This Zero Candida profile is part of a paid investor education campaign.*

Click here to connect with Zero Candida (TSXV:CZT) to receive an Investor Presentation

This post appeared first on investingnews.com

previous post
Women’s basketball league Unrivaled secures $28M in funding from star-studded investor lineup
next post
First Helium Provides Year End Corporate Update

You may also like

CHARBONE Hydrogen Initiates Discussion with Natural Hydrogen Exploration...

September 18, 2024

Adrian Day: Gold Stock Valuations at 40 Year...

March 8, 2025

Crypto Market Recap: Coinbase Hit by US$400 Million...

May 17, 2025

Bitcoin Well Infinite Launches OTC Service In Multiple...

October 29, 2024

CoTec Commissions BBA to Lead Feasibility Study for...

October 16, 2025

Argentina Lithium Announces Receipt of Drill Permit for...

October 31, 2024

Announcement by Cyclone Metals Ltd

November 22, 2024

Awalé Hits 1.4 g/t Gold Eq. over 60...

March 3, 2025

FireFly Metals Gets Approval to Dual List on...

December 14, 2024

FPX Nickel Commences Scoping Study to Develop North...

September 16, 2024

Recent Posts

  • Red Cross receives two coffins of deceased hostages in Gaza Strip, IDF says
  • Trump surgeon general nominee confirmation hearing postponed as she goes into labor
  • Vance to meet with Duffy, aviation leaders as shutdown ‘gravely’ impacts crucial industry
  • Once a trade war weapon, US soybeans return to China’s shopping list
  • Republican senators blast FDA for expanding abortion pill access

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (946)
    • Investing (3,314)
    • Politics (4,055)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.